Elevated expression of the proto-oncogene c-kit in patients with mastocytosis

Leukemia

Volumn 12, Issue 2, 1998, Pages 175-181

  Nagata, H ^a   Worobec, A S ^a   Semere, T ^a   Metcalfe, D D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

c kit; Mast cells; Mastocytosis; Stem cell factor

Indexed keywords

MESSENGER RNA; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; MALE; MASTOCYTOSIS; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; ONCOGENE C KIT; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0031951222     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400906     Document Type: Article

References (37)

1. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A. Human protooncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987; 6: 3341-3351.
2. Qiu F, Ray P, Brown K, Baker PE, Jhanwar S, Ruddle FH, Besmer P. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 1988; 7: 1003-1011.
3. Crosier PS, Ricciardi ST, Hall LR, Vitas MR, Clark SC, Crosier KE. Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 1993; 82: 1151-1158.
4. Reith AD, Ellis C, Lyman SD, Anderson DM, Williams DE, Bernstein A, Pawson T. Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO J 1991; 10: 2451-2459.
5. Nocka K, Majumder S, Chabot B, Prabir R, Cervone M, Bernstein A, Besmer P. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice. Evidence for an impaired c-kit kinase in mutant mice. Genes Devel 1989; 3: 816-826.
6. Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner A. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 1989; 78: 30-37.
7. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S, Kunisada T, Suclo T, Kina T, Nakauchi H, Nishikawa S. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 1991; 174: 63-71.
8. Papayannopoulou T, Brice M, Broucly VC, Zsebo KM. Isolation of c-kit receptor expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenie profile. Blood 1991; 78: 1403-1417.
9. Reisbach G, Bartke I, Kempkes B, Kostka C, Ellwart I, Birner A, Thalmeier K, Mailhammer R, Bornkamm GW, Ullrich A, Dörmer P. Characterization of hemopoietic cell populations from human cord blood expressing c-kit. Exp Hematol 1993; 21: 74-79.
10. Yamaguchi Y, Gunji Y, Nakamura M, Hayakawa K, Maeda M, Osawa H, Nagayoshi K, Kasahara T, Suda T. Expression of c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells. Exp Hematol 1993; 21: 1233-1238.
11. Orr-Urtreger A, Avivi A, Zimmer Y, Givol D, Yarden Y, Lonai P. Developmental expression of c-kit, a proto-oncogene encoded by the W locus. Development 1990; 109: 911-923.
12. Manova K, Bachvarova RF. Expression of c-kit encoded at the W locus of mice in developing embryonic germ cells and presumptive melanoblasts. Dev Biol 1991; 146: 312-324.
13. Funasaka Y, Boulton T, Cobb M, Yarden Y, Fan B, Lyman SD, Williams DE, Anderson DM, Zakut R, Mishima Y, Halaban R. c-kit Kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 1992; 3: 197-209.
14. Manova K, Nocka K, Besmer P, Bachvarova RF. Gonadal expression of c-kit encoded at the W locus of the mouse. Development 1990; 110: 1057-1069.
15. Morrison-Graham K, Takahashi Y. Steel factor and c-kit receptor: from mutants to a growth factor system. Bioessays 1993; 15: 77-83.
16. Hashimoto K, Tsujimura T, Moriyama Y, Yamatondani A, Kimura M, Tohya K, Morimoto M, Kitayama H, Kanakura Y, Kitamura Y. Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-clependent mast cell line. Am J Pathol 1996; 148: 189-200.
17. Tsujimura T, Morimoto M, Hashimoto K, Moriyama Y, Kitayama H, Matsuzawa Y, Kitamura Y, Kanakura Y. Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxamembrane domain. Blood 1996; 87: 273-283.
18. Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci USA 1991; 88: 8696-8699.
19. Fleishman RA, Saltman DL, Stastny V, Zneimer S. Deletion of the c-kit protooncogene in the human developmental defect piebald trait. Proc Natl Acad Sci USA 1991; 88: 10885-10889.
20. Fleischman RA. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene. J Clin Invest 1992; 89: 1713-1717.
21. Spritz RA, Holmes SA, Ramesar R, Greenberg J, Curtis D, Beighton P. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism. Am J Hum Genet 1992; 51: 1058-1065.
22. Siitonen T, Savolainen ER, Koistinen P. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes. Leukemia 1994; 8: 631-637.
23. Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991; 96 (Suppl): 2S-4S.
24. Longley J, Morganroth GS, Tyrrell L, Ding TG, Anderson DM, Williams DE, Halaban R. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. New Engl J Med 1993; 328: 1302-1307.
25. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients with mastocytosis. Proc Natl Acad Sci USA 1995; 92: 10560-10564.
26. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92: 1736-1744.
27. Butterrfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from A patient with mast cell leukemia. Leukemia Res 1988; 12: 345-355.
28. Longley BJ, Tyrrell L, Lu S-Z, Ma Y-S, Langley K, Ding T-Q, Duffy T, Jacobs P, Tang LH, Modlin T. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasms. Nat Genet 1996; 12: 312-315.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
30. Maxam AM, Gilbert W. A new method for sequencing DNA. Proc Natal Acad Sci USA 1977; 74: 560-564.
31. Gelfand DH, White TJ. Thermostable DNA polymerases. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). PCR Protocols. Academic Press: San Diego, 1990, pp 129-136.
32. Rottem M, Okada T, Goff JP, Metcalfe DD. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc∈RI-cell population. Blood 1994; 84: 2489-2496.
33. Travis WD, Li CY, Hoagland HC, Travis LB, Banks PM. Mast cell leukemia, report of a case and review of the literature. Mayo Clin Proc 1986; 61: 957-966.
34. + bone marrow progenitor cells. J Immunol 1991; 146: 1410-1415.
35. Kirshonbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD. Effect of IL-3 and stem cell factor on the appearance of human basophil and mast cells from CD34+ pluripotent progenitor cells. J Immunol 1992; 148: 772-777.
36. Agis H, Willheim M, Sperr WR, Willing A, Krömer E, Kabrna E, Spanblöchl E, Strobl H, Geissler K, Spittler A, Boltz-Nituleseu G, Majdic O, Lechner K, Valent P. Monocytes do not make mast cells when cultured in the presence of CF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. J Immunol 1993; 151: 4221-4227.
37. Piao X, Curtis JE, Minkin S, Minden MD, Bernstein A. Expression of the Kit and Kit A receptor isoforms in human acute myelogenous leukemia. Blood 1994; 83: 476-481.